Amgen AMGN
NASDAQ AMGN
$439.26 -8.02 (-1.79%)
At close: Oct 23, 2026 · 4:00 PM EDT

Amgen (AMGN) Total Non-Current Liabilities (2009 - 2026)

Updated

Amgen (AMGN) reported Total Non-Current Liabilities of $81.11 billion for Q2 2026, up 4.0% from $77.96 billion a year earlier and up 0.7% from the prior quarter.

Analysis

Amgen (AMGN) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends

At the end of FY2025, Amgen posted Total Non-Current Liabilities of $79.24 billion, down 5.2% from FY2024.

  • Total Non-Current Liabilities has a five-year compound annual growth rate of 8.2% (FY2020 to FY2025).
  • By year, Total Non-Current Liabilities came in at $83.61 billion in FY2024 (-3.0%), $86.24 billion in FY2023 (+40.9%), $61.19 billion in FY2022 (+13.1%) and $54.12 billion in FY2021 (+1.2%).
  • The Q2 2026 figure ranks as the highest quarterly Total Non-Current Liabilities since Q4 2024.
  • Year over year, Total Non-Current Liabilities gained in 1 of the last eight quarters, with an average decline of 3.3%.
  • The high point for year-over-year Total Non-Current Liabilities in five years was Q2 2023 (growth of 62.3%); the low point was Q2 2025 (a decline of 8.1%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $80.55 billion (Q1 2026), $79.24 billion (Q4 2025) and $77.91 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 60.66 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 102.65 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 106.45 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 80.25 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 48.34 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 33.91 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 78.66 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 35.10 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 97.04 Bn
10 Vertex Pharmaceuticals 133.09 Bn 105.09 Bn 2.84 Bn 5.92 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 78.66 Bn
Mar 31, 2026 78.19 Bn
Dec 31, 2025 76.86 Bn
Sep 30, 2025 75.68 Bn
Jun 30, 2025 75.62 Bn
Mar 31, 2025 78.53 Bn
Dec 31, 2024 83.61 Bn
Sep 30, 2024 78.88 Bn
Jun 30, 2024 84.88 Bn
Mar 31, 2024 87.86 Bn
Dec 31, 2023 83.92 Bn
Sep 30, 2023 82.78 Bn
Jun 30, 2023 83.24 Bn
Mar 31, 2023 83.10 Bn
Dec 31, 2022 61.19 Bn
Sep 30, 2022 51.49 Bn
Jun 30, 2022 48.32 Bn
Mar 31, 2022 48.90 Bn
Dec 31, 2021 54.12 Bn
Sep 30, 2021 48.13 Bn
API Access

Amgen Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=AMGN&period=max&api_key=YOUR_API_KEY